NO994902L - Breast cancer prevention by selective estrogen receptor modulators - Google Patents
Breast cancer prevention by selective estrogen receptor modulatorsInfo
- Publication number
- NO994902L NO994902L NO994902A NO994902A NO994902L NO 994902 L NO994902 L NO 994902L NO 994902 A NO994902 A NO 994902A NO 994902 A NO994902 A NO 994902A NO 994902 L NO994902 L NO 994902L
- Authority
- NO
- Norway
- Prior art keywords
- breast cancer
- estrogen receptor
- receptor modulators
- selective estrogen
- cancer prevention
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 3
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title 1
- 239000000333 selective estrogen receptor modulator Substances 0.000 title 1
- 229940095743 selective estrogen receptor modulator Drugs 0.000 title 1
- -1 pyrrolidino, methylpyrrolidino, dimethylpyrrolidino, piperidino, morpholino Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 201000008275 breast carcinoma Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Den foreliggende oppfinnelsen tilveiebringer en fremgangsmåte for forebygging av brystkarsinom eller kreft hos en pasient som innbefatter administrering av en terapeutisk effektiv mengde av en forbindelse som har strukturen (I) (O hvori R1 og R2 er uavhengig hydroksy eller alkoksy med en til fire karbonatomer; og R3 og R4 er uavhengig metyl eller etyl eller R3 og R4 sammen med nitrogenatomet som de er bundet til danner en pyrrolidino, metylpyrrolidino, dimetylpyrrolidino, piperidino, morfolino eller heksametylenimino ring.The present invention provides a method for preventing breast carcinoma or cancer in a patient which includes administering a therapeutically effective amount of a compound having structure (I) (O wherein R 1 and R 2 are independently hydroxy or alkoxy having one to four carbon atoms; and R3 and R4 are independently methyl or ethyl or R3 and R4 together with the nitrogen atom to which they are attached form a pyrrolidino, methylpyrrolidino, dimethylpyrrolidino, piperidino, morpholino or hexamethyleneimino ring.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4311897P | 1997-04-09 | 1997-04-09 | |
| PCT/US1998/006989 WO1998045286A1 (en) | 1997-04-09 | 1998-04-07 | Prevention of breast cancer with selective estrogen receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994902D0 NO994902D0 (en) | 1999-10-08 |
| NO994902L true NO994902L (en) | 1999-12-07 |
Family
ID=21925594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994902A NO994902L (en) | 1997-04-09 | 1999-10-08 | Breast cancer prevention by selective estrogen receptor modulators |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0975628A4 (en) |
| JP (1) | JP2001518897A (en) |
| KR (1) | KR20010006215A (en) |
| CN (1) | CN1259945A (en) |
| AU (1) | AU6957398A (en) |
| CA (1) | CA2286207A1 (en) |
| EA (1) | EA199900910A1 (en) |
| HU (1) | HUP0001845A2 (en) |
| ID (1) | ID23653A (en) |
| IL (1) | IL132279A0 (en) |
| NO (1) | NO994902L (en) |
| PL (1) | PL336206A1 (en) |
| TR (1) | TR199903244T2 (en) |
| WO (1) | WO1998045286A1 (en) |
| ZA (1) | ZA982818B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610706B1 (en) | 1999-07-29 | 2003-08-26 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| US6653479B1 (en) | 1999-07-29 | 2003-11-25 | Eli Lilly And Company | Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride |
| JP5558358B2 (en) | 2007-10-16 | 2014-07-23 | レプロス セラピューティクス インコーポレイティド | TRANS-clomiphene for metabolic syndrome |
| JP2015508825A (en) | 2012-02-29 | 2015-03-23 | レプロス セラピューティクス インコーポレイティド | Combination therapy to treat androgen deficiency |
| CA2899030C (en) | 2013-02-19 | 2021-03-09 | Novartis Ag | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders |
| GB201311888D0 (en) * | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| AU2016352592B2 (en) | 2015-11-10 | 2023-04-27 | Paracrine Therapeutics Ab | Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5510357A (en) * | 1995-02-28 | 1996-04-23 | Eli Lilly And Company | Benzothiophene compounds as anti-estrogenic agents |
| SG64896A1 (en) * | 1995-02-28 | 1999-05-25 | Lilly Co Eli | Benzothiophene compounds intermediates compositions and methods |
| US5731342A (en) * | 1996-02-22 | 1998-03-24 | Eli Lilly And Company | Benzothiophenes, formulations containing same, and methods |
-
1998
- 1998-04-02 ZA ZA9802818A patent/ZA982818B/en unknown
- 1998-04-07 KR KR1019997009295A patent/KR20010006215A/en not_active Withdrawn
- 1998-04-07 EA EA199900910A patent/EA199900910A1/en unknown
- 1998-04-07 WO PCT/US1998/006989 patent/WO1998045286A1/en not_active Ceased
- 1998-04-07 EP EP98915368A patent/EP0975628A4/en not_active Withdrawn
- 1998-04-07 HU HU0001845A patent/HUP0001845A2/en unknown
- 1998-04-07 PL PL98336206A patent/PL336206A1/en unknown
- 1998-04-07 CA CA002286207A patent/CA2286207A1/en not_active Abandoned
- 1998-04-07 AU AU69573/98A patent/AU6957398A/en not_active Abandoned
- 1998-04-07 CN CN98805957A patent/CN1259945A/en active Pending
- 1998-04-07 ID IDW991189A patent/ID23653A/en unknown
- 1998-04-07 JP JP54309098A patent/JP2001518897A/en active Pending
- 1998-04-07 TR TR1999/03244T patent/TR199903244T2/en unknown
- 1998-04-07 IL IL13227998A patent/IL132279A0/en unknown
-
1999
- 1999-10-08 NO NO994902A patent/NO994902L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA982818B (en) | 1999-10-04 |
| AU6957398A (en) | 1998-10-30 |
| EA199900910A1 (en) | 2000-04-24 |
| PL336206A1 (en) | 2000-06-05 |
| EP0975628A1 (en) | 2000-02-02 |
| EP0975628A4 (en) | 2001-03-21 |
| ID23653A (en) | 2000-05-11 |
| KR20010006215A (en) | 2001-01-26 |
| CN1259945A (en) | 2000-07-12 |
| CA2286207A1 (en) | 1998-10-15 |
| TR199903244T2 (en) | 2000-05-22 |
| JP2001518897A (en) | 2001-10-16 |
| IL132279A0 (en) | 2001-03-19 |
| NO994902D0 (en) | 1999-10-08 |
| HUP0001845A2 (en) | 2001-06-28 |
| WO1998045286A1 (en) | 1998-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO994901L (en) | Treatment of central nervous disorders by selective estrogen receptor modulators | |
| DE69523169D1 (en) | Use of mangiferin or its derivatives for cosmetic use | |
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| DK0958296T3 (en) | Heterocyclic Compounds, Methods of Preparation and Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes and Related Diseases | |
| HUP0001192A2 (en) | The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity | |
| LU93229I2 (en) | "Pitolisant and its pharmaceutically acceptable salts, such as hydrochloride" | |
| MX9800577A (en) | 4,5-diaryl oxazole derivatives. | |
| DE69516866D1 (en) | STEREOCHEMICAL WORDMAN DERIVATIVES | |
| ATE211732T1 (en) | N-BENZYLPIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES | |
| DK166383C (en) | N-PHENYL-BENZAMIDE DERIVATIVES, PROCEDURES FOR PREPARING IT, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE | |
| NO922380D0 (en) | SUBSTITUTED 4-PHENYL-4-PIPERIDINE CARBOXAMIDS WITH BOTH LOCAL ANESTHETIC AND ANALGETIC EFFECT AND PROCEDURES FOR THEIR PREPARATION | |
| NO304379B1 (en) | 11,21-Bisphenyl-19-norpregnan derivatives, their use and pharmaceutical preparations containing such derivatives | |
| NO942952L (en) | 11-benzaldoxyn-17 aters, a process for their preparation and a medicament containing such | |
| GB9718903D0 (en) | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
| ES2123546T3 (en) | USE OF 1- (AMINOALKYL) -3-QUINOXALINE-2-ONA DERIVATIVES FOR THE PREPARATION OF NEUROPROTECTORAL COMPOSITIONS. | |
| BR0011865A (en) | aromatic and heterocyclic derivatives of phytoterols and / or phytostanols for use in the treatment and prevention of cardiovascular disease | |
| NO994902L (en) | Breast cancer prevention by selective estrogen receptor modulators | |
| NO994903L (en) | Treatment or prophylaxis of prostate cancer and benign prostate hyperplasia with selective estrogen receptor modulators | |
| MX9805023A (en) | 1-methylcarbapenem derivatives. | |
| SE8100403L (en) | CYCLOHEXENE DERIVATIVES | |
| PT71949B (en) | Process for the preparation of new derivatives of 6,7-benzomor-phan having pharmaceutical effect | |
| TR199900286A2 (en) | Pyrrolidine ve piperidin t�revleri. | |
| NO983444L (en) | Benzo (c) quinolizine derivatives, their preparation and use as 5 <alfa> reductase inhibitors | |
| IL100955A (en) | Amino-polyhydroxy- cyclopentane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| AU3285000A (en) | 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |